JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 146, Issue 1, 129-138, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


ALTERATIONS OF ADRENERGIC RESPONSES BY N-ISOPROPYLMETHOXAMINE

Bernard Levy 1

1 Department of Pharmacology, New York Medical College, Flower-Fifth Avenue Hospitals, New York, N. Y.

We have found that N-isopropylmethoxarnine (IMA) and methoxamine are not typical beta adrenergic receptor blocking agents. They differ from dichloroisoproterenol (DCI) and nethalide in that they do not block any of the responses to beta adrenergic receptor activation in the anesthetized dog. However, in the isolated rat uterus, IMA and methoxamine produce a blockade of the catecholamine induced inhibitory response that is specific and that resembles closely the blockade produced by DCI and nethalide.

We have previously reported that the rat uterus possesses only beta adrenergic inhibitory receptors. IMA and methoxamine have also been reported to produce a blockade of the catecholamine induced increase in glucose and free fatty acids. This is a blockade that is also produced by the classical beta adrenergic receptor blocking agents DCI and nethahide. Two possible explanations are cited. First, IMA and methoxamine might be considered to be more specific beta adrenergic receptor blocking agents than DCI and nethalide in that they block beta adrenergic receptors only in certain tissues. Second, the receptor of the rat uterus is a different type of beta adrenergic receptor in that it is blocked by IMA and methoxamine as well as DCI and nethalide.




This article has been cited by other articles:


Home page
The Journal of the Royal Society for the Promotion of HealthHome page
{beta}-Blockers Continued from page 21
Perspectives in Public Health, February 1, 1978; 98(1): 48 - 49.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.